文献速递头颈外科

早期口腔鳞状细胞癌N0颈部管理:系统评价与Meta分析

Management of N0 neck in early oral squamous cell carcinoma: A systematic review and meta-analysis.
PubMed 文献 · Laryngoscope · 2018-12-20

该系统评价与Meta分析纳入39篇文献(5项随机对照试验和34项回顾性研究,超过4300例患者),评估早期口腔鳞状细胞癌隐匿性淋巴结转移发生率及择区性颈淋巴结清扫(END)与观察对区域复发的影响。结果显示总体隐匿性淋巴结转移发生率为23%,T2肿瘤发生隐匿性淋巴结转移的比值比显著高于T1肿瘤(OR:2.6,95%CI:2.0-3.4),观察组区域复发比值比显著高于END组(OR:4.18,95%CI:2.78-6.28),但存在显著的跨研究异质性。作者认为END应保留用于II期肿瘤,I期癌症观察可能更合适。

要点

  • 总体隐匿性淋巴结转移发生率为23%。
  • T2肿瘤发生隐匿性淋巴结转移的比值比显著高于T1肿瘤(OR:2.6,95%CI:2.0-3.4)。
  • 观察组区域复发比值比显著高于END组(OR:4.18,95%CI:2.78-6.28),但存在显著跨研究异质性。

核心结论

  • 作者认为END应保留用于II期肿瘤,因为其隐匿性转移率显著更高;I期癌症观察可能更合适。

研究设计与样本

  • 系统评价与Meta分析,检索MEDLINE、Google Scholar和Scopus,纳入39篇文献(5项随机对照试验和34项回顾性研究),共超过4300例患者。
  • 采用随机效应模型生成比值比(OR),比较T1与T2肿瘤隐匿性转移发生率以及END与观察患者的区域复发率。

主要发现

  • 按研究规模加权的总体隐匿性淋巴结转移发生率为23%。
  • T2肿瘤发生隐匿性淋巴结转移的比值比显著高于T1肿瘤(OR:2.6,95%CI:2.0-3.4)。
  • 观察组区域复发比值比显著高于END组(OR:4.18,95%CI:2.78-6.28),但观察到显著的跨研究异质性。

关键数值与推荐

  • T2肿瘤对比T1肿瘤发生隐匿性淋巴结转移的OR为2.6(95%CI:2.0-3.4)。
  • 观察组对比END组区域复发的OR为4.18(95%CI:2.78-6.28)。

临床怎么用

  • 作者认为END应保留用于II期肿瘤,I期癌症观察可能更合适。

局限性

  • 观察到显著的跨研究异质性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The role of elective neck dissection (END) in patients with stage I (T1N0) and II (T2N0) squamous cell carcinoma of the oral cavity remains a controversial topic. We investigate the need for END by establishing a true incidence of occult nodal disease as a function of T stage DATA SOURCES: MEDLINE, Google Scholar, Scopus. REVIEW METHODS: Studies were selected using a set of inclusion and exclusion criteria. Meta-analysis using a random-effects model was employed to generate an odds ratio (OR) comparing the incidence of occult metastasis between T1 and T2 tumors, as well as regional recurrence rates between patients receiving END versus observation. RESULTS: Thirty-nine publications comprising five randomized controlled trials and 34 retrospective studies were selected for inclusion, yielding over 4,300 patients for analysis. The overall incidence of occult nodal metastasis, weighted by study size, was found to be 23%. Patients with T2 tumors have a significantly higher odds of having occult nodal disease (OR: 2.6, 95% confidence interval [CI]: 2.0-3.4) over patients with T1 tumors. We also demonstrate that for patients who are observed, the odds of recurrence are significantly higher (OR: 4.18, 95% CI: 2.78-6.28) compared to those who undergo END, although statistically significant interstudy heterogeneity was observed. CONCLUSIONS: END should be reserved for stage II tumors given the significantly higher rate of occult metastasis. Observation may be more appropriate for stage I cancers. Laryngoscope, 129:E284-E298, 2019.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Massey C, Dharmarajan A, Bannuru RR, et al. Management of N0 neck in early oral squamous cell carcinoma: A systematic review and meta-analysis. Laryngoscope. 2018. PMID: 30570760. doi:10.1002/lary.27627

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。